SIMONE ADLER: Open Payments
NPI 1437881109 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 46 payments from 9 companies in 2025. Trend: 2023 $133 · 2024 $971 · 2025 $1,187
Food & beverage: $997Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $328 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $294 |
| Regeneron Healthcare Solutions, Inc. | 4 | $142 |
| Incyte Corporation | 5 | $116 |
| ABBVIE INC. | 5 | $107 |
| PFIZER INC. | 4 | $102 |
| Lilly USA, LLC | 2 | $45 |
| Botanix SB Inc | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: TREMFYA, Winlevi, DUPIXENT, OPZELURA, SKYRIZI, CIBINQO, TALTZ, SOFDRA.
Industry payments across NY — which companies pay providers there.
